An independent digest of the PT-141 literature — a billboard of the evidence, not a storefront.

What Get PT-141 is

Get PT-141 is an independent editorial project that publishes summaries of the peer-reviewed research literature on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site exists because PT-141 sits in an unusual spot: it is a genuinely FDA-approved drug with a real trial record, yet most of what is written about it online blurs the one approved use into a long list of unapproved ones. Our job is to keep those straight — to state plainly what the trials and the label establish, and to mark just as plainly where the evidence is early-phase or absent.

How we handle the evidence

Two rules govern this site. First, every quantitative clinical claim is cited to a source — a PubMed study, the FDA prescribing information, or an NIH monograph — and the references page lists them in full. Second, we keep cited clinical evidence and unverified community reports in visibly separate places: the trial and label data carry citations and live in the research sections; the "field reports" are explicitly labeled as anecdotal, carry no citation, and are never presented as evidence or as a dosing protocol.

We also state what is disputed. Where a study has an Expression of Concern, we say so at the point we cite it. Where an effect is statistically real but clinically modest, we say that too.

What the name means

"Get PT-141" is a plain, direct, no-nonsense register — a billboard of the evidence, not an offer to obtain anything. The name does not imply that this site sells, sources, or supplies PT-141; it does not. We list no prices, no vendors, and no purchase routes. Material sold elsewhere as "PT-141 research chemical" is laboratory material outside the pharmaceutical-approval framework, and bremelanotide proper is a prescription drug — neither is available here. This is a reading surface for the literature, and that is the entire scope of what we do.